ASTRIA THERAPEUTICS INC (ATXS) Stock Balance Sheet
NASDAQ:ATXS - Nasdaq - US04635X1028 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 48.43M | 167.82M | 18.60M | 84.70M | 1.90M | |||
| Cash Equivalents | 32.47M | 7.71M | 1.90M | 1.90M | 23.00M | |||
| Marketable Securities | 263.38M | 71.00M | 205.90M | 39.00M | 20.00M | |||
| Other Current Assets | 7.58M | 4.41M | 1.30M | 1.50M | 1.40M | |||
| Total Current Assets | 351.86M | 250.94M | 227.70M | 127.10M | 46.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.39M | 363.00K | 900.00K | 400.00K | 1.00M | |||
| Other Non-Current Assets | 4.39M | 3.36M | 2.00M | 0.00 | 200.00K | |||
| Total Non-Current Assets | 9.78M | 3.72M | 2.90M | 400.00K | 1.20M | |||
| TOTAL ASSETS | 361.64M | 254.67M | 230.60M | 127.50M | 47.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 14.45M | 10.04M | 8.30M | 3.60M | 4.80M | |||
| Accounts Payable | 1.28M | 1.51M | 800.00K | 1.60M | 1.50M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 15.72M | 11.55M | 9.10M | 5.20M | 6.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.26M | 0.00 | 400.00K | 0.00 | 400.00K | |||
| Total Non-Current Liabilities | 4.26M | 0.00 | 300.00K | 0.00 | 400.00K | |||
| TOTAL LIABILITIES | 19.98M | 11.55M | 9.40M | 5.20M | 6.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -649.17M | -580.53M | -507.60M | -455.80M | -260.90M | |||
| Additional Paid In Capital | 895.11M | 728.28M | 632.50M | 481.70M | 301.50M | |||
| Common Shares | 95.38M | 95.36M | 96.40M | 96.40M | 0.00 | |||
| Other Shareholders' Equity | 331.00K | 0.00 | -100.00K | 0.00 | N/A | |||
| Shares Outstanding | 56.43M | 41.03M | 27.50M | 13.00M | 3.30M | |||
| Tangible Book Value per Share | 4.36 | 3.60 | 4.54 | 1.99 | 12.33 | |||
| Total Shareholders' Equity | 341.65M | 243.12M | 221.20M | 122.30M | 40.70M | |||
| TOTAL LIABILITIES AND EQUITY | 361.64M | 254.67M | 230.60M | 127.50M | 47.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 22.38 | 21.73 | 25.02 | 24.44 | 7.23 | |||
| Return On Assets (ROA) | -27.66% | -28.62% | -22.48% | -172.04% | -78.53% | |||
| Return On Equity (ROE) | -29.28% | -29.98% | -23.43% | -179.35% | -91.65% | |||
All data in USD , ROIC based on taxRate of 0.21